Takeda Pharmaceutical
TAK
$15.93
Share price
-2.21%
Change (1 day)
14.69%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Net assets
Net assets on the balance sheet as of June 2023 : $47.80 B
According to Takeda Pharmaceutical's latest financial reports the company has $47.80 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Takeda Pharmaceutical - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $47.70 B | 2.42% |
| 2022-03-31 | $46.57 B | -0.76% |
| 2021-03-31 | $46.93 B | 7.26% |
| 2020-03-31 | $43.75 B | -5.94% |
| 2019-03-31 | $46.52 B | 145.15% |
| 2018-03-31 | $18.97 B | 8.83% |
| 2017-03-31 | $17.43 B | -2.58% |
| 2016-03-31 | $17.89 B | -2.63% |
| 2015-03-31 | $18.38 B | -25.55% |
| 2014-03-31 | $24.69 B | 4.71% |
| 2013-03-31 | $23.58 B | -5.68% |
| 2012-03-31 | $25.00 B | -2.7% |
| 2011-03-31 | $25.69 B | 11.01% |
| 2010-03-31 | $23.14 B | 11.54% |
| 2009-03-31 | $20.75 B | -10.78% |
| 2008-03-31 | $23.26 B | 11.3% |
| 2007-03-31 | $20.89 B | 4.8% |
| 2006-03-31 | $19.94 B | 6.76% |
| 2005-03-31 | $18.68 B | 9.3% |
| 2004-03-31 | $17.09 B | 28.65% |
| 2003-03-31 | $13.28 B | 21.36% |
| 2002-03-31 | $10.94 B | 10.9% |
| 2001-03-31 | $9.87 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.86 B | 48.24% | 🇺🇸 USA |
 Novartis NVS | $51.93 B | 8.62% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.23 B | 111.75% | 🇺🇸 USA |
 Amgen AMGN | $6.78 B | -85.82% | 🇺🇸 USA |
 Sanofi SNY | $79.27 B | 65.83% | 🇫🇷 France |
 Merck MRK | $46.90 B | -1.89% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.33 B | -67.92% | 🇬🇧 UK |
 Seagen
SGEN | $2.61 B | -94.52% | 🇺🇸 USA |
 Dr. Reddy's RDY | $2.83 B | -94.07% | 🇮🇳 India |